Profile
Merida Capital Partners is a private equity firm based in New York City, USA, specializing in the cannabis industry. Founded in 2016 by Mitch Baruchowitz and Kevin Gibbs, the firm employs 17 professionals who collectively bring over 50 years of relevant experience. Merida distinguishes itself by emphasizing investments in companies with strong management teams and proven operating models, aiming to accelerate their growth in the rapidly developing cannabis sector.
The firm focuses on investing in cultivation technologies, cannabis-based products and services for medical and adult-use markets, and related pharmaceutical and recreational consumer products. They target companies that have transitioned from start-ups to revenue-generating businesses, managing $200 million in assets across five funds and co-investments. Merida is known for its strategic approach to enhancing the growth of its portfolio companies by anticipating industry trends.
Among its portfolio, Merida has investments in over 50 companies, focusing on essential products or services within the cannabis value chain. Notable companies include [List of Portfolio Companies (from site)], reflecting their commitment to identifying opportunities with significant long-term value as the cannabis industry normalizes worldwide.
Industry
Merida Capital Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
1) Merida Capital Partners I LP
|
Private Equity (PE)
|
Consumer Products
Consumer Services (B2C)
Healthcare Services
Retail
SaaS
Software
Technology
Infrastructure
HealthTech
|
Series B
|
North America
|
$5-10 m
|
$40 M
|
October 2016
|
|
Merida Capital Partners II LP
|
Private Equity (PE)
|
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
Media and Entertainment
Infrastructure
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$200 M
|
March 2019
|
|
Merida Capital Partners IV LP
|
Private Equity (PE)
|
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
Media and Entertainment
HealthTech
|
Series B
|
North America
|
$5-10 m
|
$60 M
|
October 2020
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.